RNA Technology to Regenerate and Repair Alveolar Bone Defects
Journal of Dental Research · 2024
DOI: 10.1177/00220345241242047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dental Research, 2024. Verfasst von D Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Bone Regeneration, MicroRNAs, Osteogenesis, Tooth Socket. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS.
Abstract (Originalsprache)
microRNA-200a ( miR-200a) targets multiple signaling pathways that are involved in osteogenic differentiation and bone development. However, its therapeutic function in osteogenesis and bone regeneration remains unknown. In this study, we use in vitro and in vivo models to investigate the molecular function of miR-200a overexpression and miR-200a inhibition using a plasmid-based miR inhibitor system (PMIS) on osteogenic differentiation and bone regeneration. Inhibition of miR-200a using PMIS-miR-200a significantly increased osteogenic biomarkers of human embryonic palatal mesenchyme cells and promoted bone regeneration in rat tooth socket defects. In rat maxillary M1 molar extractions, the supporting tooth structures were removed with an implant drill to yield a 3-mm defect in the alveolar bone. A collagen sponge was inserted into the open alveolar defect and PMIS-miR-200a plasmid DNA was added to the sponge and the wound sutured to protect the sponge and close the defect. It was important to remove the existing tooth supporting structure, which can influence alveolar bone regeneration. The alveolar bone was regenerated in 4 wk. The collagen sponge acts to stabilize and deliver the PMIS-miR-200a DNA to cells entering the sponge in the bone defect. We show that mesenchymal stem cells expressing CD90 and Stro-1 enter the sponges, take up the DNA, and express PMIS-miR-200a. PMIS-miR-200a initiates a bone regeneration program in transformed cells in vivo. In vitro inhibition of miR-200a was found to upregulate Wnt and BMP signaling activity as well as Runx2, OCN, Lef-1, Msx2, and Dlx5 associated with osteogenesis. Liver and blood toxicity testing of PMIS-miR-200a–treated rats showed no increase in several biomarkers of liver disease. These results demonstrate the therapeutic function of PMIS-miR-200a for rapid bone regeneration. Furthermore, the studies were designed to demonstrate the ease of use of PMIS-miR-200a in solution and applied using a syringe in the clinic through a simple one-time application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
- Center for Craniofacial Anomalies Research, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
- Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.
- Iowa Institute for Oral Health Research, College of Dentistry, University of Iowa, Iowa City, IA, USA.
ORCID-Profile: B A Amendt
Förderung
- NIDCR NIH HHS
Zitieren
APA
Su, D., Swearson, S., Eliason, S., Rice, K. G., & Amendt, B. A. (2024). RNA Technology to Regenerate and Repair Alveolar Bone Defects. Journal of Dental Research. https://doi.org/10.1177/00220345241242047
Vancouver
Su D, Swearson S, Eliason S, Rice KG, Amendt BA. RNA Technology to Regenerate and Repair Alveolar Bone Defects. Journal of Dental Research. 2024. doi:10.1177/00220345241242047
BibTeX
@article{Su2024,
author = {Su, D and Swearson, S and Eliason, S and Rice, K G and Amendt, B A},
title = {RNA Technology to Regenerate and Repair Alveolar Bone Defects},
journal = {Journal of Dental Research},
year = {2024},
doi = {10.1177/00220345241242047}
}
EUVIMED